Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Practice

Placenta accreta spectrum

Valerie Bloomfield, Stacey Rogers and Nicholas Leyland
CMAJ August 24, 2020 192 (34) E980; DOI: https://doi.org/10.1503/cmaj.200304
Valerie Bloomfield
Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ont.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stacey Rogers
Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ont.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Leyland
Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ont.
MD MHCM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Placenta accreta spectrum describes abnormally adherent or invasive placentas

In normal pregnancy, a blastocyst implants into the endometrium, and after delivery, the placenta detaches from the uterus. In placenta accreta spectrum, the placenta forms at a site of disruption between the endometrium and myometrium. Placental tissue implants onto the myometrium (accreta), into the myometrium (increta) or through the myometrium to surrounding organs (percreta) (Figure 1). This prevents placental detachment, which can result in severe hemorrhage and increased risk of maternal morbidity and mortality.1–4

Figure 1:
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1:

Intraoperative cesarean hysterectomy for placenta percreta in the context of placenta previa. The baby was delivered through a classical fundal incision (A), which was closed before the hysterectomy was begun. The placenta was left in situ with bulging, vascular placental tissue visible under the uterine serosa (B). Final pathology reported placenta percreta with invasion into the bladder wall.

The most common risk factor is multiple previous cesarean deliveries

In a large systematic review, the rate of placenta accreta spectrum increased from 0.3% in women with 1 previous cesarean delivery to 6.7% in women with 6 previous cesarean deliveries.5 Additional risk factors include uterine surgery and assisted reproduction.1–3

Placenta previa substantially increases the risk of placenta accreta spectrum

Among women with placenta previa and history of previous cesarean delivery, the risk of placenta accreta spectrum increases from 11% after 1 cesarean delivery to 60% after 3 or more cesarean deliveries.4,5 Placenta previa occurs in about 3% of pregnancies.5

Women with placenta previa and a history of cesarean delivery should have targeted ultrasounds in centres of excellence

Although findings on imaging are present throughout pregnancy, placenta accreta spectrum is commonly suspected during the routine anatomy scan performed at 18 to 20 weeks.1,4 A combination of transabdominal and transvaginal ultrasound achieves diagnostic sensitivity of 90% (95% confidence interval [CI] 87%–93%) and specificity of 97% (95% CI 96%–97%).1 Magnetic resonance imaging can be an adjunct when assessing posterior placentas and depth of invasion.1,4

Management of placenta accreta spectrum requires specialized teams

Early referral to centres of excellence reduces maternal morbidity, including the need for massive transfusion and multiple surgical interventions.1,4 Centers of excellence typically follow standardized protocols and care pathways, bringing together specialists in maternal fetal medicine, gynecology, anesthesia and neonatology, as well as allied health professionals.

Footnotes

  • Competing interests: Nicholas Leyland reports receiving research support grants from AbbVie and Allergen, and consulting fees from AbbVie. No other competing interests were declared.

  • This article has been peer reviewed.

References

  1. ↵
    1. Hobson SR,
    2. Kingdom JC,
    3. Murji A,
    4. et al
    . No. 383 — Screening, diagnosis, and management of placenta accreta spectrum disorders. J Obstet Gynaecol Can 2019;41:1035–49.
    OpenUrl
    1. Collins SL,
    2. Alemdar B,
    3. van Beekhuizen HJ,
    4. et al.
    International Society for Abnormally Invasive Placenta (ISAIP). Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. Am J Obstet Gynecol 2019;220:511–26.
    OpenUrl
  2. ↵
    1. Jauniaux E,
    2. Ayres-de-Campos D,
    3. Langhoff-Roos J,
    4. et al.
    FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet 2019;146:20–4.
    OpenUrl
  3. ↵
    Obstetric Care Consensus No. 7: Placenta accreta spectrum. Obstet Gynecol 2018;132:e259–75.
    OpenUrl
  4. ↵
    1. Marshall NE,
    2. Fu R,
    3. Guise JM
    . Impact of multiple cesarean deliveries on maternal morbidity: a systematic review. Am J Obstet Gynecol 2011;205:262.e1–8.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 192 (34)
CMAJ
Vol. 192, Issue 34
24 Aug 2020
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Placenta accreta spectrum
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Placenta accreta spectrum
Valerie Bloomfield, Stacey Rogers, Nicholas Leyland
CMAJ Aug 2020, 192 (34) E980; DOI: 10.1503/cmaj.200304

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Placenta accreta spectrum
Valerie Bloomfield, Stacey Rogers, Nicholas Leyland
CMAJ Aug 2020, 192 (34) E980; DOI: 10.1503/cmaj.200304
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Placenta accreta spectrum describes abnormally adherent or invasive placentas
    • The most common risk factor is multiple previous cesarean deliveries
    • Placenta previa substantially increases the risk of placenta accreta spectrum
    • Women with placenta previa and a history of cesarean delivery should have targeted ultrasounds in centres of excellence
    • Management of placenta accreta spectrum requires specialized teams
    • Footnotes
    • References
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Topical nonsteroidal anti-inflammatory drugs
  • Postcoital bleeding
  • Phlegmonous gastritis
Show more Practice

Similar Articles

Collections

  • Article Types
    • Five Things to Know About
  • Topics
    • Neonatal medicine
    • Obstetrics & gynecology
    • Women's health (including abortion)

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire